Cocrystal Pharma's market cap is currently ―. The company's EPS TTM is $-1.9; its P/E ratio is -0.75; Cocrystal Pharma is scheduled to report earnings on May 13, 2024, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.

	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Income Statement	-
Total Revenue	-	-	-	-	$ 0.00
Gross Profit	-	-	-	-	-
EBIT	$ -7.68M	$ -4.31M	$ 5.03M	$ -4.50M	$ -5.70M
EBITDA	$ -7.58M	$ -4.21M	$ 5.14M	$ -4.64M	$ -5.60M
Net Income Common Stockholders	$ -7.37M	$ -4.17M	$ 5.03M	$ -4.50M	$ -5.70M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 29.74M	$ 32.49M	$ 34.06M	$ 37.22M	$ 42.06M
Total Assets	$ 32.61M	$ 36.28M	$ 37.50M	$ 40.84M	$ 45.65M
Total Debt	$ 118.00K	$ 176.00K	$ 235.00K	$ 297.00K	$ 360.00K
Net Debt	$ -29.62M	$ -32.32M	$ -33.82M	$ -36.92M	$ -41.70M
Total Liabilities	$ 1.92M	$ 1.60M	$ 3.17M	$ 1.27M	$ 1.74M
Stockholders Equity	$ 30.69M	$ 34.68M	$ 34.67M	$ 39.57M	$ 43.91M
Cash Flow	-
Free Cash Flow	$ -2.68M	$ -5.56M	$ -3.16M	$ -4.91M	$ -8.97M
Operating Cash Flow	$ -2.68M	$ -5.55M	$ -3.11M	$ -4.89M	$ -8.91M
Investing Cash Flow	-	$ -14.00K	$ -45.00K	$ -12.00K	$ -62.00K
Financing Cash Flow	-	$ 4.00M	$ -7.00K	$ -7.00K	$ -7.00K

Currency in USD

Cocrystal Pharma Earnings and Revenue History

Income Statement >

Cocrystal Pharma Debt to Assets

Balance Sheet >

Cocrystal Pharma Cash Flow

Cash Flow >

Cocrystal Pharma Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing